Enantioselective determination of azelnidipine in human plasma using liquid chromatography-tandem mass spectrometry

被引:15
|
作者
Kawabata, Kiyoshi
Samata, Naozumi
Urasaki, Yoko
Fukazawa, Ichiro
Uchida, Naoki
Uchida, Eiji
Yasuhara, Hajime
机构
[1] Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Showa Univ, Sch Med, Dept Pharmacol 2, Tokyo 104, Japan
关键词
azelnidipine; enantiomer separation; quantitative analysis; LC/APCI-MS/MS;
D O I
10.1016/j.jchromb.2007.01.050
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and simple method was developed for determination of the enantiomers of azeinidipine, (R)-(-)-azelnidipine and (S)-(+)-azelnidipine, in human plasma using chiral liquid chromatography with positive ion atmospheric pressure chemical ionization tandem mass spectrometry. Plasma samples spiked with stable isotope-labeled azelnidipine, [H-2(6)]-azelnidipine, as an internal standard, were processed for analysis using a solid-phase extraction in a 96-well plate format. The azelnidipine enantiomers were separated on a chiral column containing alpha(1)-acid glycoprotein as a chiral selector under isocratic mobile phase conditions. Acquisition of mass spectrometric data was performed in multiple reaction monitoring mode, monitoring the transitions from m/z 583 -> 167 for (R)-(-)-azelnidipine and (S)-(+)-azelnidipine, and from m/z 589 -> 167 for [H-2(6)]-azelnidipine. The standard curve was linear over the studied range (0.05-20 ng/mL), with r(2) > 0.997 using weighted (1/x(2)) quadratic regression, and the chromatographic run time was 5.0 min/injection. The intra- and inter-assay precision (coefficient of variation), calculated from the assay data of the quality control samples, was 1.2-8.2% and 2.4-5.8% for (R)-(-)-azelnidipine and (S)-(+)-azelnidipine, respectively. The accuracy was 101.2-117.0% for (R)-(-)-azelnidipine and 100.0-107.0% for (S)-(+)-azelnidipine. The overall recoveries for (R)-(-)-azelnidipine and (S)-(+)azelnidipine were 71.4-79.7% and 71.7-84.2%, respectively. The lower limit of quantification for both enantiomers was 0.05 ng/mL using 1.0 mL of plasma. All the analytes showed acceptable short-term, long-term, auto-sampler and stock solution stability. Furthermore, the method described above was used to separately measure the concentrations of the azelnidipine enantionters in plasma samples collected from healthy subjects who had received a single oral dose of 16 mg of azelnidipine. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:389 / 397
页数:9
相关论文
共 50 条
  • [1] Simultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry
    Kawabata, Kiyoshi
    Urasaki, Yoko
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 844 (01): : 45 - 52
  • [2] Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry
    Liu, Ke
    Dai, Xiaojian
    Zhong, Dafang
    Chen, Xiaoyan
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 864 (1-2): : 129 - 136
  • [3] Enantioselective assay of nimodipine in human plasma using liquid chromatography-tandem mass spectrometry
    Isse, Fadumo Ahmed
    Le, Tyson
    Mahmoud, Sherif Hanafy
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (02)
  • [4] Determination of Cefotiam in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
    Du Ping
    Li Peng-Fei
    Liu Hong-Chuan
    Yu Wei-Yue
    Liu Li-Hong
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 2016, 44 (06) : 876 - 881
  • [5] Determination of benidipine in human plasma using liquid chromatography-tandem mass spectrometry
    Kang, WK
    Yun, HY
    Liu, KH
    Kwon, KI
    Shin, JG
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 805 (02): : 311 - 314
  • [6] Determination of tiropramide in human plasma by liquid chromatography-tandem mass spectrometry
    Lee, HW
    Ji, HY
    Kim, HH
    Cho, HY
    Lee, YB
    Lee, HS
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 796 (02): : 395 - 400
  • [7] Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry
    Zhao, Xia
    Liu, Yuwang
    Xu, Junyu
    Zhang, Dan
    Zhou, Ying
    Gu, Jingkai
    Cui, Yimin
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (29): : 3724 - 3728
  • [8] Determination of Mebudipine in Human Plasma by Liquid Chromatography-tandem Mass Spectrometry
    Asgari, Arezoo
    Kobarfard, Farzad
    Keyhanfar, Fariborz
    Mohebbi, Shohreh
    Noubarani, Maryam
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (03): : 739 - 746
  • [9] Determination of nicousamide in human plasma by liquid chromatography-tandem mass spectrometry
    Qi, Wenyuan
    Zhao, Qian
    Liu, Hongzhong
    Jiang, Ji
    Chen, Xiaoguang
    Hu, Pei
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 77 : 158 - 162
  • [10] Determination of telmisartan in human plasma by liquid chromatography-tandem mass spectrometry
    Li, PF
    Wang, YW
    Wang, Y
    Tang, YB
    Fawcett, JP
    Cui, YM
    Gu, JK
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 828 (1-2): : 126 - 129